 |
|
| Blog results | Results 1 - 10 of about 7,889 for clear cell ovarian cancer. (0.51 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Ovarian Cancer News Blog from medicineworld.org - http://medicineworld.org/news/ovariannews.html Libby's H*O*P*E* - http://healthinfoispower.wordpress.com/ | |
| 20 Nov 2009 by Paul Cacciatore 5/Sugiyama T & Fujiwara K. Clear Cell Tumors of the Ovary – Rare Subtype of Ovarian Cancer, Gynecologic Cancer, American Society of Clinical Oncology (ASCO) Educational Book, 2007 ASCO Annual Meeting, June 2, 2007 (Microsoft Powerpoint ... Libby's H*O*P*E* (*Helping *Ovarian Cancer... - http://healthinfoispower.wordpress.com/ - References [ More results from Libby's H*O*P*E* (*Helping *Ovarian Cancer... ] |
| 9 Nov 2009 by Sandi Pniauskas Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Posted by Sandi Pniauskas at Monday, November 09, 2009 ... OVARIAN CANCER and US - http://ovariancancerandus.blogspot.com/ [ More results from OVARIAN CANCER and US ] |
| 11 hours ago However, she adds that when it is clear that that approach is not going to work, they should stop and then do what they think will work. "Most of the time, they will be overjoyed that you showed some independence and got the right answer. ... His laboratory focuses on the role of immune cells in ovarian cancer angiogenesis and tumor antigen recognition. They are currently studying a novel population of myeloid cells as ovarian cancer biomarkers and antiangiogenic ... Überfeed of All GenomeWeb Content - http://feeds.genomeweb.com/genomeweb [ More results from Überfeed of All GenomeWeb Content ] |
| 15 Nov 2009 by Youji Feng Moreover, p53 mutations are frequently detected in patients with high-grade serous and clear cell carcinomas, which are associated with an aggressive clinical course [12], suggesting the possibility that p53 mutations mediate features of the invasive and metastatic .... Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y: Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. ... Molecular Cancer - Latest Articles - http://www.molecular-cancer.com/ - References [ More results from Molecular Cancer - Latest Articles ] |
| 28 Oct 2009 by admin The epithelial ovarian carcinomas can be classified because of some features that can be seen under the microscope into serous, mucinous, endometrioid, and clear cell types. The most common type is the serous. ... Treatment for Cancer - http://www.treatmentforcancer.co.uk/ |
| 6 Sep 2009 by admin while ovarian neoplasms are among the most common malignancies,(10) other sites have been found to undergo malignant changes as well, including clear cell carcinoma arising in an endometriosis implant in a low abdominal transverse scar ... Ovarian Cancer - http://www.free-ovarian-cancer.info/ |
| 11 Aug 2009 thus, they emphasize, “given the aggressive behavior of clear cell ovarian tumors, conservative surgical therapy should be approached with caution in these patients.” reference: cancer 2009;115. views: 1355. rating: The Doctor's Channel - http://www.thedoctorschannel.com/ |
| 17 Nov 2009 Mabuchi, S., Altomare, D.A., Cheung, M., Zhang, L., Poulikakos, P., Hensley, H.H., Schilder, R.J., Ozols, R.F. and Testa, J.R. (2007) RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, ... M., Yamoto, M., Klein-Szanto, A.J., Schilder, R.J., Ohmichi, M., Testa, J.R., Kimura, T. (2009) mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary. Clin. Cancer Res. ... Burnett School of Biomedical Sciences -... - http://www.biomed.ucf.edu/index.php?option=com_sobi2... |
| 11 Sep 2009 by tracey “For example, clear-cell carcinoma is a subcategory of ovarian cancer. It is a very, very aggressive disease and is hard to control with chemotherapy that is more useful in a papillary serous carcinoma.” The highly individual nature of ... CancerConsultants - http://www.cancerconsultants.com/ [ More results from CancerConsultants ] |
| 25 Sep 2009 RATIONALE: Screening tests, such as the lysophosphatidic acid assay, may help doctors find cancer cells early and plan better treatment for ovarian cancer. PURP... ... Stage not greater than IB; No more than superficial myometrial invasion, without vascular or lymphatic invasion; No poorly differentiated subtypes, including papillary serous, clear cell, or other FIGO grade 3 lesions; No epithelial ovarian carcinoma of low malignant potential (borderline carcinomas) ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
